Research & Discovery
Which Patients Benefit Most from Immunotherapy? This Tool Can Tell
Identifying effective treatments early can save cancer patients from months of fruitless therapies
Diagnosis from the Sky: Catching Insect Infestations within Forests Before It’s Too Late
Fine-tuning remote sensing to protect forests from the spread of dangerous critters
Language & Cognition PhD Program Receives Funding for 5 GAANN Fellows
The UConn program for language and cognition has received funding for five graduate fellows after cognitive psychology and psycholinguistics was identified as an area of national need.
Academia, Industry, and Consumers Tackle Challenges for Wearable Fitness Technology
A global group interested in wearable technologies has launched a networking hub to help ensure the quality, accuracy, and accessibility of devices
Awards and Honors
Read about the latest accolades received by our faculty and trainees.
Six From UConn Named to World’s Highly Cited Research List
The list identifies researchers who produced multiple papers ranking in the top one percent by citations for their field and year of publication
UConn Researchers: Deleting Dysfunctional Cells Alleviates Diabetes
A discovery that could lead to game-changing treatments for metabolic diseases
Quarterly Recap of Pharmacy Faculty Research Grants – FY 2021 Q4
Recapping the quarter beginning April 1, 2021 through June 30, 2021, the UConn School of Pharmacy congratulates the following Department of Pharmaceutical Science faculty and their teams for their FY 2021 Q4 research grant awards totaling $252,131:
Behind the Degree: DNP Student Plans to Use Her Advanced Education to Empower Her Patients and Other Nurses
Savitha Chandramohan is earning her Doctor of Nursing Practice degree so she can support development among her fellow nurses and reduce patients' costly hospital visits
TIP Company ImStem Biotechnology Doses First MS Patient in Clinical Trial
UConn TIP company ImSTEM Biotechnology is conducting a clinical trial to test their experimental human embryonic stem cell-derived mesenchymal stem cell therapy for the treatment of multiple sclerosis.